Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures. Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one''s self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
Scope of the Report:
This report focuses on the Cardiopulmonary Autotransfusion System in Global market, especially in North America, Europe and Asia-Pacific, Latin America, Middle and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Fresenius Kabi
- Wansong Health Sources
Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
Latin America, Middle and Africa
Market Segment by Type, covers
- Unwashed ATS
- Washed ATS
Market Segment by Applications, can be divided into
- Heart Surgery
- Great Organ Transplant Surgery
- Other Surgery
There are 13 Chapters to deeply display the global Cardiopulmonary Autotransfusion System market.
Chapter 1, to describe Cardiopulmonary Autotransfusion System Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cardiopulmonary Autotransfusion System, with sales, revenue, and price of Cardiopulmonary Autotransfusion System, in 2015 and 2016;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cardiopulmonary Autotransfusion System, for each region, from 2011 to 2016;
Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;
Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;
Chapter 11, Cardiopulmonary Autotransfusion System market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;
Chapter 12 and 13, to describe Cardiopulmonary Autotransfusion System sales channel, distributors, traders, dealers, appendix and data source.